Expert Opinion on Managing Chronic HCV in Patients with Neuropsychiatric Manifestations
Author(s) -
Daniel Forton,
Karin Weißenborn,
Mark Bondin,
P. Cacoub
Publication year - 2018
Publication title -
antiviral therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.747
H-Index - 87
eISSN - 2040-2058
pISSN - 1359-6535
DOI - 10.3851/imp3245
Subject(s) - medicine , depression (economics) , disease , quality of life (healthcare) , psychiatry , chronic fatigue syndrome , hepatitis c virus , hepatitis c , intensive care medicine , chronic infection , cognition , immunology , virus , immune system , nursing , economics , macroeconomics
Neurological manifestations of HCV infection appear to be under-recognized in clinical practice despite the majority of HCV-infected patients experiencing symptoms such as fatigue, depression and cognitive dysfunction. There is also growing evidence for a link between HCV infection and an increased risk of Parkinson's disease. The mechanism underpinning the association between HCV and these neuropsychiatric syndromes still requires further investigation. Here we review the pre-clinical and clinical evidence for a link between HCV and effects on the central nervous system leading to neuropsychiatric syndromes. Lastly, we describe how improvements in neuropsychiatric manifestations of HCV following treatment have been observed, which is subsequently reflected in an overall improvement in health-related quality of life.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom